ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,608.73
0.19%
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs Yen
157.25
0.00%
Brent Oil
81.295
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Takeda Pharmaceutical Co Ltd (PK) (TKPHF)

  7. Takeda Pharmaceutical Co Ltd (PK) (TKPHF) ニュース

TKPHF

Takeda Pharmaceutical (PK) (TKPHF)

Takeda Pharmaceutical Co Ltd (PK)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:TKPHF
日付受信時刻ニュースソース見出しコード企業名
2024/05/2919 : 29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/2919 : 29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/2919 : 29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/2919 : 24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/0919 : 08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/0919 : 04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/0919 : 03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/0919 : 02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/05/0919 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/02/0920 : 03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/02/0520 : 24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2024/02/0220 : 16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/11/3020 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/11/1320 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/10/2619 : 22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/10/2619 : 20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/10/0219 : 17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/09/2819 : 17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/07/1219 : 07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/07/1019 : 35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/07/1019 : 33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/07/1019 : 26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/07/1019 : 24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/07/1019 : 22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/07/1019 : 20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/07/1019 : 16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/07/1019 : 14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/07/1019 : 12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/07/1019 : 09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
2023/07/1019 : 06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
 Showing the most relevant articles for your search:USOTC:TKPHF

最近閲覧した銘柄

NYSE
XAN-C
Exantas Capital
NASDAQ
FTEO
FRONTEO
BIT
UB5930
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有